Starpharma Holdings Ltd (SPL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Starpharma Holdings Ltd (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10132
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s development programs include its DEP drug delivery, which is built around dendrimers, VivaGel portfolio and agrochemicals. Its flagship product candidate, VivaGel, is a gel-based formulation for the treatment and prevention of bacterial vaginosis (BV) and it is also used as a vaginal microbicide to prevent sexually transmitted infections including HIV and genital herpes. The company has license arrangements with several partners including Ansell Limited, Aspen Pharmacare, Okamoto Industries and AstraZeneca. The company has research facilities in Melbourne, Australia. Starpharma is headquartered in Melbourne, Australia.

Starpharma Holdings Ltd (SPL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Starpharma Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Starpharma to Enter into Agreement with Chinese Company 11
Starpharma Holdings Enters into Agreement with AstraZeneca 12
Licensing Agreements 13
Mundipharma Enters into Licensing Agreement with Starpharma Holding 13
Starpharma Holdings Enters into Licensing Agreement with Koushan Pharmed 14
Aspen Pharma Enters into Licensing Agreement with Starpharma 15
Shenyang Sky and Land Latex Enters into Licensing Agreement with Starpharma 16
AstraZeneca Enters into Licensing Agreement with Starpharma 17
Equity Offering 18
Starpharma Raises USD1.4 Million in Share Purchase Plan 18
Starpharma Raises USD23 Million in Private Placement of Shares 19
Starpharma Holdings Raises USD3 Million in Share Purchase Plan 21
Starpharma Raises USD16 Million in Private Placement of Shares 22
Starpharma Holdings Ltd – Key Competitors 24
Starpharma Holdings Ltd – Key Employees 25
Starpharma Holdings Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 27
Feb 26, 2018: Starpharma Interim Report and Half-Year Financial Results 28
Aug 28, 2017: Starpharma annual report and full year financial results 30
Government and Public Interest 32
Oct 09, 2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant 32
Jun 30, 2017: MIPS and Starpharma awarded STEM+ Business Fellowships to further targeted delivery technologies for cancer 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Starpharma Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Starpharma Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Starpharma to Enter into Agreement with Chinese Company 11
Starpharma Holdings Enters into Agreement with AstraZeneca 12
Mundipharma Enters into Licensing Agreement with Starpharma Holding 13
Starpharma Holdings Enters into Licensing Agreement with Koushan Pharmed 14
Aspen Pharma Enters into Licensing Agreement with Starpharma 15
Shenyang Sky and Land Latex Enters into Licensing Agreement with Starpharma 16
AstraZeneca Enters into Licensing Agreement with Starpharma 17
Starpharma Raises USD1.4 Million in Share Purchase Plan 18
Starpharma Raises USD23 Million in Private Placement of Shares 19
Starpharma Holdings Raises USD3 Million in Share Purchase Plan 21
Starpharma Raises USD16 Million in Private Placement of Shares 22
Starpharma Holdings Ltd, Key Competitors 24
Starpharma Holdings Ltd, Key Employees 25
Starpharma Holdings Ltd, Subsidiaries 26

List of Figures
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Starpharma Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Starpharma Holdings Ltd (SPL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Statkraft AS:企業の戦略・SWOT・財務分析
    Statkraft AS - Strategy, SWOT and Corporate Finance Report Summary Statkraft AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ALLETE Inc (ALE)-エネルギー分野:企業M&A・提携分析
    Summary ALLETE, Inc. (ALLETE) is an energy company that operates varied businesses in the energy sector. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. It provides energy in the upper Midwest in the US; and inves …
  • Xped Ltd (XPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • Post Holdings, Inc.:戦略・SWOT・企業財務分析
    Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HearMeOut Ltd (HMO):企業の財務・戦略的SWOT分析
    HearMeOut Ltd (HMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Websol Energy System Ltd (WEBELSOLAR):企業の財務・戦略的SWOT分析
    Summary Websol Energy System Ltd (Websol) is an alternate energy company that offers manufacturing of photovoltaic crystalline solar cells and the related modules. The company offers products such as pv solar cell and pv solar module. Its pv solar cell includes multi crystalline 4bb pv solar cell, m …
  • Fiesta Mart LLC:企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Desjardins Financial Security Life Assurance Company:企業の戦略・SWOT・財務情報
    Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Gurit Holding AG (GUR):企業の財務・戦略的SWOT分析
    Gurit Holding AG (GUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Acobiom:企業の製品パイプライン分析
    Summary Acobiom (Acobiom) is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification …
  • Ubiquiti Networks Inc
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • Shuttle Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shuttle Pharmaceuticals Inc (Shuttle), formerly Shuttle Pharmaceuticals LLC is a developer of therapies that offers novel drugs for improving cancer treatment outcomes. The company’s pipeline products comprise therapies such as SP-2-001, SP-1-161, SP-1-003 and SP-3-001. Its therapies are use …
  • Singapore Technologies Engineering Ltd (S63):企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • MediciNova Inc (MNOV)-製薬・医療分野:企業M&A・提携分析
    Summary MediciNova Inc (MediciNova) is a biopharmaceutical company, which focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs such as MN-001, for the treatm …
  • The Western Union Company:企業のM&A・事業提携・投資動向
    The Western Union Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Western Union Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Total Brain Ltd (TTB):企業の財務・戦略的SWOT分析
    Summary Total Brain Ltd (TBL) formerly, Brain Resource Ltd is a healthcare service provider that offers therapies. The company carries out research and development of brain products. TBL’s products comprise iSPOT, Total Brain and MyBrainSolutions. The company’s Total Brain is a brain health solution …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆